BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

119 related articles for article (PubMed ID: 37633006)

  • 21. Astragaloside IV inhibits colorectal cancer metastasis by reducing extracellular vesicles release and suppressing M2-type TAMs activation.
    Zhou J; Li L; Pu Y; Li H; Wu X; Wang Z; Sun J; Song Q; Zhou L; Ma X; Yang L; Ji Q
    Heliyon; 2024 May; 10(10):e31450. PubMed ID: 38831823
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Astragaloside IV alleviates macrophage senescence and d-galactose-induced bone loss in mice through STING/NF-κB pathway.
    Li M; Niu Y; Tian L; Zhang T; Zhou S; Wang L; Sun J; Wumiti T; Chen Z; Zhou Q; Ma Y; Guo Y
    Int Immunopharmacol; 2024 Mar; 129():111588. PubMed ID: 38290207
    [TBL] [Abstract][Full Text] [Related]  

  • 23. PCSK9 promotes the progression and metastasis of colon cancer cells through regulation of EMT and PI3K/AKT signaling in tumor cells and phenotypic polarization of macrophages.
    Wang L; Li S; Luo H; Lu Q; Yu S
    J Exp Clin Cancer Res; 2022 Oct; 41(1):303. PubMed ID: 36242053
    [TBL] [Abstract][Full Text] [Related]  

  • 24. KLF14 alleviated breast cancer invasion and M2 macrophages polarization through modulating SOCS3/RhoA/Rock/STAT3 signaling.
    Chu J; Hu XC; Li CC; Li TY; Fan HW; Jiang GQ
    Cell Signal; 2022 Apr; 92():110242. PubMed ID: 34998931
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Taraxacum mongolicum extract inhibited malignant phenotype of triple-negative breast cancer cells in tumor-associated macrophages microenvironment through suppressing IL-10 / STAT3 / PD-L1 signaling pathways.
    Deng XX; Jiao YN; Hao HF; Xue D; Bai CC; Han SY
    J Ethnopharmacol; 2021 Jun; 274():113978. PubMed ID: 33716082
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Dihydroartemisinin Prevents Progression and Metastasis of Head and Neck Squamous Cell Carcinoma by Inhibiting Polarization of Macrophages in Tumor Microenvironment.
    Chen R; Lu X; Li Z; Sun Y; He Z; Li X
    Onco Targets Ther; 2020; 13():3375-3387. PubMed ID: 32425545
    [TBL] [Abstract][Full Text] [Related]  

  • 27. YAP/STAT3 inhibited CD8
    Wang C; Shen N; Guo Q; Tan X; He S
    Cancer Med; 2023 Aug; 12(15):16295-16309. PubMed ID: 37329188
    [TBL] [Abstract][Full Text] [Related]  

  • 28. hUC-MSCs exosomal miR-451 alleviated acute lung injury by modulating macrophage M2 polarization via regulating MIF-PI3K-AKT signaling pathway.
    Liu J; Xing F; Fu Q; He B; Jia Z; Du J; Li Y; Zhang X; Chen X
    Environ Toxicol; 2022 Dec; 37(12):2819-2831. PubMed ID: 35997581
    [TBL] [Abstract][Full Text] [Related]  

  • 29. CEBPA Restrains the Malignant Progression of Breast Cancer by Prompting the Transcription of SOCS2.
    Wang JL; Ji WW; Huang AL; Liu Z; Chen DF
    Mol Biotechnol; 2024 May; ():. PubMed ID: 38775935
    [TBL] [Abstract][Full Text] [Related]  

  • 30. LHX6 inhibits the proliferation, invasion and migration of breast cancer cells by modulating the PI3K/Akt/mTOR signaling pathway.
    Bi QJ; Men XJ; Han R; Li GL
    Eur Rev Med Pharmacol Sci; 2018 May; 22(10):3067-3073. PubMed ID: 29863252
    [TBL] [Abstract][Full Text] [Related]  

  • 31. M2 polarization of macrophages by Oncostatin M in hypoxic tumor microenvironment is mediated by mTORC2 and promotes tumor growth and metastasis.
    Shrivastava R; Asif M; Singh V; Dubey P; Ahmad Malik S; Lone MU; Tewari BN; Baghel KS; Pal S; Nagar GK; Chattopadhyay N; Bhadauria S
    Cytokine; 2019 Jun; 118():130-143. PubMed ID: 29625858
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Dauricine regulates prostate cancer progression by inhibiting PI3K/AKT-dependent M2 polarization of macrophages.
    Li M; Che N; Liu X; Xuan Y; Jin Y
    Biochem Pharmacol; 2023 Nov; 217():115838. PubMed ID: 37778445
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Mechanism of M2 macrophages modulating astrocyte polarization through the TGF-β/PI3K/Akt pathway.
    Pang QM; Zhang Q; Wu XC; Yang RL; Fu SP; Fan ZH; Liu J; Yu LM; Peng JC; Zhang T
    Immunol Lett; 2023 Jul; 259():1-8. PubMed ID: 37244460
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Diosmetin inhibits the growth and invasion of gastric cancer by interfering with M2 phenotype macrophage polarization.
    Zhang F; Luo H
    J Biochem Mol Toxicol; 2023 Oct; 37(10):e23431. PubMed ID: 37377034
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Saikosaponin d modulates the polarization of tumor-associated macrophages by deactivating the PI3K/AKT/mTOR pathway in murine models of pancreatic cancer.
    Xu X; Cui L; Zhang L; Yang L; Zhuo Y; Li C
    Int Immunopharmacol; 2023 Sep; 122():110579. PubMed ID: 37433245
    [TBL] [Abstract][Full Text] [Related]  

  • 36. MED1 induces M2 polarization of tumor-associated macrophages to aggravate breast cancer.
    Shen Y; Zhou L; Xu M; Tan Z; Yao K; Wang W
    Genes Genomics; 2023 Dec; 45(12):1517-1525. PubMed ID: 37594664
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Ferroptosis-dependent breast cancer cell-derived exosomes inhibit migration and invasion of breast cancer cells by suppressing M2 macrophage polarization.
    Yi C; Wu S; Duan Q; Liu L; Li L; Luo Y; Wang A
    PeerJ; 2023; 11():e15060. PubMed ID: 36949762
    [TBL] [Abstract][Full Text] [Related]  

  • 38. β-Glucan produced by Lentinus edodes suppresses breast cancer progression via the inhibition of macrophage M2 polarization by integrating autophagy and inflammatory signals.
    Zhu F; Zhang Q; Feng J; Zhang X; Li T; Liu S; Chen Y; Li X; Wu Q; Xue Y; Alitongbieke G; Pan Y
    Immun Inflamm Dis; 2023 May; 11(5):e876. PubMed ID: 37249285
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Anemoside A3 activates TLR4-dependent M1-phenotype macrophage polarization to represses breast tumor growth and angiogenesis.
    Yin L; Fan Z; Liu P; Chen L; Guan Z; Liu Y; Luo Y
    Toxicol Appl Pharmacol; 2021 Dec; 432():115755. PubMed ID: 34673087
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Tetrastigma polysaccharide reprogramming of tumor-associated macrophages via PPARγ signaling pathway to play antitumor activity in breast cancer.
    Liu X; Liu X; Mao W; Guo Y; Bai N; Jin L; Shou Q; Fu H
    J Ethnopharmacol; 2023 Oct; 314():116645. PubMed ID: 37196813
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.